Enveric Biosciences (NASDAQ:ENVB) is a biotech firm dedicated to developing innovative solutions designed to improve patient lives, focusing primarily on those suffering from cancer. Operating in the life sciences sector, Enveric is engaged in cutting-edge research and development activities, aimed at creating a portfolio of novel therapeutic candidates. Their projects span from the development of supportive care therapies to advancing the potential uses of cannabinoids in medical treatments, highlighting their commitment to exploring new frontiers in medicine. The objective of Enveric is to address unmet medical needs through the power of modern bioscience, ensuring better health outcomes for patients worldwide.